119 related articles for article (PubMed ID: 10675722)
21. Local and Systemic IL-7 Concentration in Gastrointestinal-Tract Cancers.
Bednarz-Misa I; Diakowska D; Krzystek-Korpacka M
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31185636
[TBL] [Abstract][Full Text] [Related]
22. The role of proteolytic enzymes in cancer invasion and metastasis.
Duffy MJ
Clin Exp Metastasis; 1992 May; 10(3):145-55. PubMed ID: 1582084
[TBL] [Abstract][Full Text] [Related]
23. Proteases and their inhibitors in human brain tumours: a review.
Rooprai HK; McCormick D
Anticancer Res; 1997; 17(6B):4151-62. PubMed ID: 9428349
[TBL] [Abstract][Full Text] [Related]
24. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
Baker EA; Bergin FG; Leaper DJ
Mol Pathol; 2000 Dec; 53(6):307-12. PubMed ID: 11193049
[TBL] [Abstract][Full Text] [Related]
26. An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis.
Allgayer H; Babic R; Grützner KU; Beyer BC; Tarabichi A; Wilhelm Schildberg F; Heiss MM
Cancer; 1997 Jul; 80(2):179-87. PubMed ID: 9217027
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
28. Fibrinolysis components as prognostic markers in breast cancer and colorectal carcinoma.
Gandolfo GM; Conti L; Vercillo M
Anticancer Res; 1996; 16(4B):2155-9. PubMed ID: 8694536
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal dysplasia.
Sharma P; Montgomery E
Pathology; 2013 Apr; 45(3):273-85. PubMed ID: 23442738
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic, clinicopathologic, therapeutic and prognostic value of Plasma Heat Shock Protein 90 levels in patients with advanced Gastrointestinal Carcinoma.
Zhang Y; Ni L; Li Q; Li M; Zhu J; Zhang F; Gu K
J Cancer; 2020; 11(20):5890-5899. PubMed ID: 32922531
[No Abstract] [Full Text] [Related]
31. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
32. Dysplasia in the gastrointestinal tract: definition and clinical significance.
Hermanek P
Surg Endosc; 1987; 1(1):5-10. PubMed ID: 3504051
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B.
Kobayashi H; Ohi H; Sugimura M; Shinohara H; Fujii T; Terao T
Cancer Res; 1992 Jul; 52(13):3610-4. PubMed ID: 1617632
[TBL] [Abstract][Full Text] [Related]
34. Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer.
Schmitt M; Goretzki L; Jänicke F; Calvete J; Eulitz M; Kobayashi H; Chucholowski N; Graeff H
Biomed Biochim Acta; 1991; 50(4-6):731-41. PubMed ID: 1801751
[TBL] [Abstract][Full Text] [Related]
35. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of the plasminogen activator inhibitor type 1--a multifaceted proteolytic factor.
Harbeck N; Krüger A; Sinz S; Kates RE; Thomssen C; Schmitt M; Jänicke F
Onkologie; 2001 Jun; 24(3):238-44. PubMed ID: 11455216
[TBL] [Abstract][Full Text] [Related]
37. Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages.
Abdulla MH; Valli-Mohammed MA; Al-Khayal K; Al Shkieh A; Zubaidi A; Ahmad R; Al-Saleh K; Al-Obeed O; McKerrow J
Oncol Rep; 2017 Jun; 37(6):3175-3180. PubMed ID: 28440429
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion.
Persky B; Ostrowski LE; Pagast P; Ahsan A; Schultz RM
Cancer Res; 1986 Aug; 46(8):4129-34. PubMed ID: 3524801
[TBL] [Abstract][Full Text] [Related]
39. Association of interleukin-8 and plasminogen activator system in the progression of colorectal cancer.
Terada H; Urano T; Konno H
Eur Surg Res; 2005; 37(3):166-72. PubMed ID: 16088182
[TBL] [Abstract][Full Text] [Related]
40. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer.
Taponeco F; Curcio C; Giuntini A; Nardini V; Fornaciari G; Artini PG; D'Ambrogio G; Genazzani AR
J Exp Clin Cancer Res; 2001 Jun; 20(2):239-46. PubMed ID: 11484981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
